Latest News on Pfizer Inc. (PFE) Stock

  • Pfizer Inc. (PFE) Closes 0.6% Down on the Day for March 03 [March 3 2015 02:07 PM]
  • Pfizer Inc. (PFE) Closes 0.6% Down on the Day for March 03   Equities.com - 1 hour ago Pfizer Inc. currently has a total float of 6.13 billion shares and moves 31.78 million a day, on average. The stock opened at $34.75 on March 03 and traded between a low of $34.41 and a high of $34.89. Read more about this Pfizer Inc. (PFE) news
  • Interesting June Stock Options for Pfizer [March 2 2015 09:48 AM]
  • Interesting June Stock Options for Pfizer   Forbes - Mar 2, 2015 So unless Pfizer Inc sees its shares decline 7.7% and the contract is exercised (resulting in a cost basis of $31.58 per share before broker commissions, subtracting the 42 cents from $32), the only upside to the put seller is from collecting that ... Read more about this Pfizer Inc. (PFE) news


  • Pfizer, Inc., Novartis AG Criticize CDC's Recommendation For Meningitis B ... [February 27 2015 06:15 AM]
  • Pfizer, Inc., Novartis AG Criticize CDC's Recommendation For Meningitis B ...   Bidness ETC - Feb 27, 2015 Pfizer Inc. (NYSE:PFE) and Novartis AG (ADR) (NYSE:NVS) on Thursday received a green signal from the US Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) for their meningitis B vaccines, for people ... Pfizer, Novartis say me... Read more about this Pfizer Inc. (PFE) news


  • NICE Okays Pfizer Inc. Inlyta, Rejects Dendreon Corporation Provenge; Bad ... [February 25 2015 03:15 AM]
  • NICE Okays Pfizer Inc. Inlyta, Rejects Dendreon Corporation Provenge; Bad ...   Bidness ETC - Feb 25, 2015 The National Institute for Health and Care Excellence (NICE) issued two final guidelines today, recommending Pfizer Inc.'s (NYSE:PFE) Inlyta (axitinib) to be used as a second-line treatment option for kidney cancer, while rejecting Dendreon Corporation ... Read more about this Pfizer Inc. (PFE) news
  • CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination for Persons at Increased Risk [March 3 2015 06:05 AM]
  • [at noodls] - Pfizer Inc. (NYSE: PFE) announced today that the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend serogroup B meningococcal vaccination ... Read more about this Pfizer Inc. (PFE) news
  • Pfizer Receives European Approval for New Indication for Prevenar 13 for Prevention of Vaccine-Type Pneumococcal Pneumonia in Adults [March 3 2015 06:05 AM]
  • [at noodls] - Pfizer Inc. (NYSE:PFE) announced today that the European Commission approved an expanded indication for the use of Prevenar 13 *(pneumococcal polysaccharide conjugate vaccine ) for ... Read more about this Pfizer Inc. (PFE) news

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center